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Calcium supplementation amongst postmenopausal women: Effect on serum 
calcium, phosphorus and magnesium level
Abstract
This study assessed the effect of calcium supplementation towards the change in serum calcium, 
phosphorus and magnesium level. We carried out a randomized controlled trial of calcium 
supplementation in 113 postmenopausal women for 24 months period study. Subjects were 
randomly assigned into two groups. Subjects in Calcium Supplemented Group (CSG) were to 
take calcium supplement (1200 mg/day) while the Control Group were not given any placebo 
and advised to continue with their regular diet. The study showed that calcium supplementation 
helps to increased daily intake of calcium amongst the subject which in results helping to 
maintain the serum calcium level within normal range. The serum magnesium and phosphorus 
level in this study were kept at a normal range although there is a slight decrease in serum 
phosphorus levels may be due to a reduction in the daily intake of the mineral.
Introduction
The use of calcium supplements from pills, 
chewable tablets and other formulation has increased 
because the community has become concerned about 
calcium deficiency in their bone health. In Malaysia, 
consumption of calcium supplements is gaining 
popularity as there were 35.7% (Foo and Zaitun, 
2000) and 78% (Chee et al., 1998) postmenopausal 
women in the study who took calcium supplement 
on a regular basis. During the next decade, the 
increasing awareness of the importance of calcium 
supplementation in preventing osteoporosis will 
further expand the market. 
The role of nutritional factors in the etiology 
of osteoporosis is controversial. However adequate 
nutrition does influence all aspects of bone health 
throughout human life cycle. Calcium is particularly 
important in elderly women because low dietary 
intake have been associated with reduced bone mineral 
density (BMD) (Dawson-Hudges et al., 1990; Prince 
et al., 1995; Reid et al., 1995). Postmenopausal 
women need to obtain sufficient amounts of calcium 
to maintain bone health and suppress parathyroid 
hormone (PTH) (Mc Kane et al., 1996). In addition 
to its function in building and maintaining bones and 
teeth, calcium also has numerous metabolic roles 
in cells and in other tissues (Nordin, 1997). Even 
though only small amounts of calcium required for 
these roles, it is good to remember that it also gives a 
big impact to the calcium homeostasis. 
Phosphorus and magnesium are among minerals 
that have been proposed as having an important role 
in bone metabolisms. Phosphorus, as phosphates 
combine with calcium ions to form hydroxyapatite, 
the major inorganic molecule in teeth and bones. 
Magnesium (Mg) is an essential intracellular cation, a 
cofactor of many basic cellular processes, particularly 
those involving energy metabolisms (Heaney, 2001). 
Individuals with low calcium to phosphorus serum 
(Ca:P serum) ratio would benefit from increasing 
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Epidemiologic studies have demonstrated a positive 
correlation between dietary Mg intake and bone 
density and/or an increased rate of bone loss with low 
dietary intake suggesting that dietary Mg deficiency 
may be a risk factor for osteoporosis. In vivo study 
for calcium bioavailability however, has shown 
tendencies towards lowering serum phosphorus and 
magnesium level. Though there has been study on 
beneficial effect of calcium towards BMD, there are 
few data in regard to the biochemical status. The 
objective of this study was to assess the effect of long 
term calcium carbonate supplementation on serum 
calcium, phosphorus and magnesium level.
Materials and Methods
Subjects
This randomized controlled trial of calcium 
supplementation was a preplanned sub-study of 
a larger trial that assessed the effects of calcium 
supplementation on bone health. The entry criteria 
for the main study required that subjects be 
postmenopausal for more than 5 years and aged 
between 50 to 65 years old. Women with history of 
bone disease and receiving therapy for osteoporosis 
were ineligible, as were those with any other 
medical conditions that affect bone metabolism, 
including hypothyroidism or hyperthyroidism, liver 
disease, malignancy or metabolic bone disease. 
None of the subjects had been regular users of 
calcium supplements, hormone replacement therapy 
(bisphosphonate, estrogen, tamoxifen or testosterone), 
anabolic steroids, glucocorticoids, anticonvulsants 
or any other drugs known to affect calcium or bone 
metabolism within the past year. 
Women were recruited by health screening test 
done in the selected area. Of the 236 post menopausal 
women assessed for eligibility for the study, only 
173 meet the entry criteria but 60 were elected not 
to proceed. Thus, 113 women entered the study 
and randomly assigned to calcium supplementation 
group (CSG) and control group (CG). Subjects in 
CSG received 1200 mg of elemental calcium daily 
as the carbonate, CaCO3 (Caltrate, WhiteHall USA) 
while CG were not given any placebo and advised 
to continue with their regular diet and lifestyle. The 
supplemented subjects were asked to take 600-mg 
tablets twice a day after meal in the morning and in 
the evening. 
Data Collection
Subjects’ demographic background and lifestyle 
were assessed using validated questionnaire. Dietary 
intakes were assessed using the Three-Day Food 
Record and analyzed using Nutrionist IV Diet 
Analysis Version 4.1 (First Data Bank 1995 The 
Hearst Corp., USA). Compliance was assessed by 
tablet counts. Serum levels of calcium, magnesium 
and phosphorus were measured using Dimension 
Clinical Chemistry System (Dade International Inc., 
Deerfield, IL, USA) autoanalyzer. Intact PTH ( hPTH 
1-84), PTHi level were determined using DiaSorin 
N-tact PTH SP IRMA kit (DiaSorin Inc., MN, USA) 
which is based on immunoradiometric assay (IRMA). 
All data were collected during baseline, at 12 months 
and 24 months. Statistical analyses were performed 
using The Statistical Package for the Social Sciences 
(Windows version 10.05 SPSS).
Results
Clinical characteristics of the study subjects 
are shown in Table 1. Mean age of the subjects at 
baseline was 60+4 years and with a mean of 11+5 
years post menopause. Physical characteristic of 
subjects were similar in both groups. There was no 
significant difference between group in calcium, 
phosphorus and magnesium intake at baseline. Mean 
intake for calcium among subjects were low when 
compared to Recommended Nutrient Intake (RNI) 
for Malaysian (NCCFN, 2005) which recommend 
intake of 1000 mg/day for elderly aged 50 to 65 years 
old. Almost 78% had calcium intake less than 2/3 of 
recommended value. 
Calcium supplementation had been found to help 
increase daily calcium level intake among subjects in 
CSG (Table 2). This situation had increased calcium 
to phosphorus ratio from 0.5 to 2.1 for the group. 
However, subject in both groups had decreased their 
phosphorus intake (significantly difference (p<0.05) 
from baseline) at 12 and 24 months. There was no 
significant change in magnesium intake among 
subjects in both groups. 
The serum levels determined in this study were 
within normal range in both groups.  Changes in 
biochemical measurements are shown in Table 1. 
Serum calcium in CSG had been significantly higher 
compared to CG at the end of this study. There was a 
decrement of -1.4% (at 24 months) in calcium serum 
level among subject CG. The calcium level in CSG 
however, had been similar to baseline level though 
there was a slight decrement during 12 months. PTHi 
level had been decreased in both group, which is 
significantly higher in CSG compared to CG. 
Dietary intake of calcium and Ca:P  ratio had been 
found positively correlated with serum calcium level. 
Dietary phosphorus also had been shown to influence 
the Ca:P serum ratio, while increment in magnesium 
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intake had been statistically found to reduce PTHi 
level (Table 3). 
Discussion
This study identified a low dietary calcium intake 
situation among the subjects. A low calcium intake is 
universally reported in Asian countries (Tan, 2002). 
The result of this study should be cited as a reason for 
encouraging the Malaysians to increase their calcium 
intake. The key to bone health lies in the body’s 
calcium balance. Calcium’s vital role in intracellular 
communications and other body processes require 
that the concentration of ionized calcium in plasma 
be regulated within narrow limits (Gurr, 1999). The 
skeleton serves as a bank from which the blood can 
borrow and return calcium as needed. If the ‘saving 
account’ is not sufficient, then it will develop the 
fragile bones of osteoporosis. Maintaining serum 
calcium level through sufficient dietary intake could 
prevent this from happening or at least would slow 
down one of the consequences of aging which is bone 
loss (Reid et al., 1993). This study proved that the 
use of calcium carbonate supplements in a daily dose 
containing 1200 mg of elemental calcium is sufficient 
in helping to maintain constant serum calcium level. 
The suppression of PTHi occurs significantly higher 
in calcium group, likely in respond to the increased 
concentration of calcium ions in plasma as a result 
of increased intake. This “negative feedback” 
mechanism would keep the serum calcium within 
normal range (Nordin, 1997b). 
It was good to find that subject’s magnesium 
serum level had been increased throughout the time 
study. An in vivo assessment by (Patwardhan et al. 
(2001) had shown a tendency of hypomagnesemic, 
however this was only happened in competitive 
environment created by the presence of extra calcium 
in the normocalcemic animals. Magnesium is needed 
for the normal function of parathyroid glands, and its 
deficiency markedly disturbs calcium homeostasis 
leading to hypocalcemia (Rude et al., 2005), which 
explained the negative correlation between the 
mineral and PTH found (Table 3). Postmenopausal 
women with osteoporosis have also been reported to 
have a low serum magnesium concentration (Martini 
and Meyer, 1999). 
Serum phosphorus showed a tendency to 
reduce might be caused by decreased intake by the 
subjects. Though the change was not significant, 
the situation should not be encouraged. Study 
by (Chapuy et al., 1992), found elderly women 
given calcium and vitamin D supplements, with or 
without anti-osteoporosis drugs developed a risk 
for hypophosphatemia which would prevent bone 
recovery process. However in this study it is likely 
that phosphorus intake is, in fact sufficiently high for 
most subjects. It is calcium that is mainly deficient 
in their diets. However, supplementing calcium with 
Table 1. Clinical characteristics of the study subjects, by randomized 
group   assignment
Characteristic Control Calcium
Age (years) 59.3 ± 3.7 60.0 ± 3.4
Duration of menopause (years) 10.7 ± 4.8 11 ± 4.8
Weight (kg) 62.9 ± 11.8 60.9 ± 9.9
Height (m) 1.51 ± 0.04 1.53 ± 0.06
BMI (kg/m2) 27.6 ± 5.3 26.1 ± 4.3
Compliance (%) - 91.7%














Control 545 ± 295 492 ± 293α 467 ± 221α 1.4 ± 67.6
Calcium 496 ± 239 1602 ± 263 1600 ± 134 295 ± 163
Dietary phosphorus (mg)
Control 1055 ± 455 910 ± 344 903 ± 321 -10.9 ± 40.1
Calcium 1012 ± 363 834 ± 280 800 ± 226 -7.8 ± 41.0
Dietary magnesium (mg)
Control 176 ± 78 167 ± 59 178 ± 79 8.0 ± 47.2
Calcium 175 ± 71 159 ± 63 168 ± 46 6.5 ± 48.1
Dietary calcium : 
phosphorus ratio
Control 0.5 ± 0.3 0.6 ± 0.3 0.5 ± 0.2 -
Calcium 0.5 ± 0.3 2.1 ± 0.6 2.1 ± 0.5 -
Serum calcium (mmol/L)
Control 2.30 ± 0.11 2.26 ± 0.09 2.27 ± 0.08α -1.4 ± 4.9
Calcium 2.32 ± 0.09 2.29 ± 0.09 2.32 ± 0.11 0.0 ± 4.4
Serum phosphorus 
(mmol/L)
Control 1.16 ± 0.11 1.20 ± 0.13 1.14 ± 0.12 -0.9 ± 11.2
Calcium 1.18 ± 0.14 1.16 ± 0.12 1.15 ± 0.15 -1.5 ± 15.2
Serum magnesium 
(mmol/L)
Control 0.74 ± 0.09 0.76 ± 0.08 0.78 ± 0.10 5.9 ± 10.4
Calcium 0.71 ± 0.08 0.74 ± 0.09 0.77 ± 0.08 8.1 ± 12.1
Serum calcium : 
phosphorus ratio
Control 2.0 ± 0.2 1.9 ± 0.2 2.0 ± 0.2 -
Calcium 1.9 ± 0.3 2.0 ± 0.2 2.0 ± 0.3 -
PTHi (pmol/L) Control 2.64 ± 0.95 2.78 ± 1.10 2.09 ± 0.97 -9.0 ± 45.2
Calcium 2.74 ± 1.15 2.47 ± 0.93 1.88 ± 0.80 -26.0 ± 29.9
α
α Significant difference between group at time determined p<0.01α Si nifican  differ nc  between group at time determined p<0.01
Table 3. Correlation between dietary and serum level






Calcium serum 0.321b 0.160 0.282b -0.026
Phosphorus 
serum
-0.057 -0.208 0.021 0.066
Ca:P serum 0.148 0.278a 0.052 -0.059
Magnesium 
serum
0.077 0.085 0.054 -0.033
PTHi -0.098 -0.166 0.129 -0.241a
a Significant correlation at p<0.05    , b Significant correlation at p<0.01
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phosphate should be encouraged especially in elderly 
who tend to have a low food phosphorus intake. 
Conclusion
Calcium supplementation amongst 
postmenopausal women benefits them by increasing 
the subject daily intake of calcium. Sufficient intake 
of calcium maintains serum calcium level, and 
suppresses PTH secretion. 
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